Summary: S.2577 — 101st Congress (1989-1990)All Information (Except Text)

There is one summary for S.2577. Bill summaries are authored by CRS.

Shown Here:
Introduced in Senate (05/03/1990)

Amends the Internal Revenue Code to extend through 1993 the tax credit for clinical testing expenses for certain drugs for rare diseases or conditions. Includes preclinical testing expenses under such tax credit.

Provides for determining the credit recapture amount when using preclinical testing of a drug for a disease or condition that has not previously been designated as a rare disease or condition.